Genetic Engineering: Principles and Methods – serie

The current volume covers human gene therapy, improving the nutritional value of maize, restriction-modification enzymes, and eight other subjects.

Volume 17 of this highly acclaimed series features discussions on a new method of mapping and manipulating DNA with the use of RecA protein in combination with restriction enzymes, RNA pseudoknots, and platelet-derived growth factors and their receptors in cell differentiation and cell cycle control.

Volume 18 explores the latest advances in recombinant DNA molecule techniques and how they are revolutionizing basic research in biology. Chapters discuss obtaining good expression of genetically engineered pest-resistant genes introduced in crop plants, cloning DNAs containing palindromes, and identifying genes by 3' terminal exon trapping and much more.

The newest installment in this superb series presents descriptions of the latest DNA recombinants molecule technology. The text combines reports on basic research in genetics with discussions of specific new industrial applications (as well as refinements of older ones) that are likely to prove highly profitable in the years to come.

Aspects of genetic engineering research emphasized in this volume are applications to plants (crop plants and grass, both important for human needs) and new methodologies, such as Tar cloning, which make it much easier to isolate specific regions from complex genomes. Another subject discussed is linear DNA replication of prokaryotes.

This volume, as with the previous books in the series, presents state-of-the-art discussions in genetics and genetic engineering by focusing on plant science and technology, agriculture, cell biology, and medical research.

This volume presents state-of-the-art discussions in Genetics and Genetic engineering by focusing on plant science and technology, transport protein biochemistry, cell biology and gene therapy research.

This volume contains an eclectic mix of articles on the different aspects of genetics and genetic engineering research - all pieces on topics of contemporary interest. It presents state-of-the-art discussions of genetics and genetic engineering, focusing on new genetic methodologies, including DNA transcription, gene therapy, and plant science, among others.

"Genetic Engineering, Volume 25" contains discussions of contemporary and relevant topics in genetics, including: genotyping by mass spectrometry; development of targeted viral vectors for cardiovascular gene therapy; practical applications of rolling circle amplification of DNA templates; bacterial ION channels; applications of plant antiviral proteins; and the bacterial scaffoldin - structure, function and potential applications in the nanosciences. This principles and methods approach to genetics and genetic engineering should be of interest to all academics, bench scientists and industry professionals wishing to take advantage of the latest knowledge in this continuously emerging field.

Genetic Engineering: Principles and Methods presents state-of-the-art discussions in modern genetics and genetic engineering. Recent volumes have covered gene therapy research, genetic mapping, plant science and technology, transport protein biochemistry, and viral vectors in gene therapy, among many other topics.Key features of Volume 27 include:- Identification and Analysis of Micrornas- Dormancy and the Cell Cycle- Long distance peptide and metal transport in plants- Signaling in plant response to temperature and water stresses- Nutrient transport and metabolism in plants- Salt Stress Signaling and Mechanisms of Plant Salt Tolerance- Gene cloning and expression- Assisted folding and assembly of proteins

This focus affirms a commitment to publish important reviews of the broadest interest to geneticists and their colleagues in affiliated disciplines.Recent volumes have covered gene therapy research, genetic mapping, plant science and technology, transport protein biochemistry, and viral vectors in gene therapy, among other topics.

This focus affirms a commitment to publish important reviews of the broadest interest to geneticists and their colleagues in affiliated disciplines.Recent volumes have covered gene therapy research, genetic mapping, plant science and technology, transport protein biochemistry, and viral vectors in gene therapy, among other topics.

Genetic Engineering, Volume 25 contains discussions of contemporary and relevant topics in genetics, including: - Genotyping by Mass Spectrometry;- Development of Targeted Viral Vectors for Cardiovascular Gene Therapy;

Genetic Engineering, Volume 24 contains discussions of contemporary and relevant topics in genetics, including: -Gene silencing: principles and applications, -Integrins and the myocardium, -Plant virus gene vectors: biotechnology and applications in agriculture and medicine, -Novel approaches to controlling transcription, -Use of DNA polymorphisms in genetic mapping, -Application of FLP/FRT site-specific DNA recombination system in plants.This principles and methods approach to genetics and genetic engineering is essential reading for all academics, bench scientists, and industry professionals wishing to take advantage of the latest and greatest in this continuously emerging field.

This volume, as with the previous books in the series, presents state-of-the-art discussions in genetics and genetic engineering by focusing on plant science and technology, agriculture, cell biology, and medical research.

Aspects of genetic engineering research emphasized in this volume are applications to plants (crop plants and grass, both important for human needs) and new methodologies, such as Tar cloning, which make it much easier to isolate specific regions from complex genomes. Another subject discussed is linear DNA replication of prokaryotes.

The newest installment in this superb series presents descriptions of the latest DNA recombinants molecule technology. The text combines reports on basic research in genetics with discussions of specific new industrial applications (as well as refinements of older ones) that are likely to prove highly profitable in the years to come.

This volume is the first of a series concerning a new tech- nology which is revolutionizing the study of biology, perhaps as profoundly as the discovery of the gene. As pointed out in the introductory chapter, we look forward to the future impact of the technology, but cannot see where it might take us. The purpose of these volumes is to follow closely the explosion of new tech- niques and information that is occurring as a result of the newly- acquired ability to make particular kinds of precise cuts in DNA molecules. Thus we are particularly committed to rapid publication. Jane K. Setlow Alexander Hollaender v INTRODUCTION AND HISTORICAL BACKGROUND 1 Maxine F. Singer CLONING OF DOUBLE-STRANDED cDNA . . 15 Argiris Efstratiadis and Lydia Vi11a-Komaroff GENE ENRICHMENT . . * * ...37 M. H. Edgell, S. Weaver, Nancy Haigwood and C. A. Hutchison III 51 TRANSFORMATION OF MAMMALIAN CELLS ...M. Wig1er, A. Pe11icer, R. Axel and S. Silverstein CONSTRUCTED MUTANTS OF SIMIAN VIRUS 40 73 D. Short1e, J. Pipas, Sondra Lazarowitz, D. DiMaio and D. Nathans STRUCTURE OF CLONED GENES FROM XENOPUS: A REVIEW 93 R. H. Reeder TRANSFORMATION OF YEAST 117 Christine lIgen, P. J. Farabaugh, A.Hinnen, Jean M. Walsh and G. R. Fink THE USE OF SITE-DIRECTED MUTAGENESIS IN REVERSED GENETICS 133 C. Weissmann, S. Nagata, T. Taniguchi, H. Weber and F. Meyer AGROBACTERIUM TUMOR INDUCING PLASMIDS: POTENTIAL VECTORS FOR THE GENETIC ENGINEERING OF PLANTS . 151 P. J. J. Hooykaas, R. A. Schi1peroort and A.

Like many genetic engineers, I have recently been receiving the atten­ tion of various venture capital companies, international drug houses and Members of Parliament. I will not discuss which of these approaches are most welcome, but it did cause me to consider the speed of advance in genetic engineering, and the implications of this rapid growth. There were few who anticipated it - only five years ago, most scientists thought applications would come at the end of the century, yet we see products such as insulin and interferon already available for clinical testing. In Europe in general and Britain in particular, this explosive growth in our own field has coincided with a general industrial depression and a marked reduction in funding for biomedical research. The brain drain from Britain is a serious matter, for we are losing the best of our younger scientists, on whom we would rely to train the next generation of molecular biologists. These volumes have come from British labs (mostly because I happen to be based in London, and my contacts and friends are here), and I feel that the quality of the con­ tributions also shows that our current research is of a high standard.